Tulip Formulations Private Limited
About Tulip Formulations Private Limited
Data last updated:
Tulip Formulations Private Limited is a private limited company based in Indora, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2005PTC028713. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.7 Cr and a paid-up capital of ₹1.7 Cr. It is led by directors Jagjit Singh Chahal and Paramjit Singh.
Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office is at Village Surajpur Upla Tehsil Indora, Himachal Pradesh, India – 176001.
As per the financials filed for FY 2015, the company reported a revenue of ₹2.21 Cr, a growth of 58% compared to the previous year. For the same year it recorded a net loss of ₹32.83 Lakh (net margin -14.9%) and EBITDA of ₹60.99 Lakh (EBITDA margin 27.6%).
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.25 Cr and satisfied charges of ₹2.43 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Tulip Formulations Private Limited's registered office is in Indora, Himachal Pradesh.
- Registered AddressVillage Surajpur Upla Tehsil Indora, Himachal Pradesh, India – 176001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Tulip Formulations Private Limited
FY 2015 filings availableTulip Formulations Private Limited reported revenue of ₹2.21 Cr (up 58% YoY) for FY 2015.
Compounded Annual Growth Rate (CAGR)
Revenue rose 58% in the latest year. EBITDA fell 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹60.99 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹32.83 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | 27.6% |
| Net Profit Margin | -14.9% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Tulip Formulations Private Limited, buy the company report.
Board of directors of Tulip Formulations Private Limited
Tulip Formulations has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagjit Singh Chahal | Director | 02 Jul 2011 | 15 Years 3 Months | Current |
| Paramjit Singh | Director | 02 Jul 2011 | 15 Years 3 Months | Current |
Peer comparison
Tulip Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Manmohini Pharmaceuticals Private Limited | ₹2.21 Cr (FY 2025) | Murshidabad, West Bengal, India | ||||
| Mendel Pharma Private Limited | ₹2.21 Cr (FY 2024) | 1.0% | Hyderabad, Telangana, India | |||
| Indinex Private Limited | ₹2.21 Cr (FY 2018) | -81.0% | Navi Mumbai, Maharashtra, India | |||
| Scion Pharma Private Limited | ₹2.21 Cr (FY 2025) | 41.0% | Gandhinagar, Gujarat, India | |||
| Cinicot Private Limited | ₹2.21 Cr (FY 2024) | -82.0% | Mohali, Punjab, India | |||
| Tulip Formulations Private Limitedthis company | ₹2.21 Cr (FY 2015) | -₹32.83 Lakh | -14.9% | 58.0% | Indora, Himachal Pradesh, India | |
| Esvy Life Sciences Private Limited | ₹2.21 Cr (FY 2025) | 20.0% | Begumpet, Hyderabad, Telangana, India | |||
| Ciel Pharma Private Limited | ₹2.2 Cr (FY 2022) | 20.0% | Lucknow, Uttar Pradesh, India | |||
| Hariansh Pharmaceuticals Private Limited | ₹2.19 Cr (FY 2024) | 270.0% | Nashik, Maharashtra, India | |||
| Sugen Pharma Private Limited | ₹2.19 Cr (FY 2025) | 45.0% | Ahmedabad, Gujarat, India | |||
| Cellbless Healthcare Private Limited | ₹2.19 Cr (FY 2023) | 0.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Tulip Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2012 | 10345400 | State Bank of India | ₹4.25 Cr | Open | |
| 12 Apr 2007 | 10051749 | State Bank of Patiala | ₹2.43 Cr | Satisfied |
To see the full charge records of Tulip Formulations Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Tulip Formulations Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
To see the full case history of Tulip Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tulip Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tulip Formulations has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Tulip Formulations Private Limited, buy the company report.
Recent activity
Tulip Formulations Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Jagjit Singh Chahal ceased to be Additional Director on 05 Jul 2011.
4 earlier events are in the company report.
Frequently asked questions
Tulip Formulations is an active private limited company based in Indora, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 2005 (21+ years old) and is registered under CIN U24230HP2005PTC028713.
Tulip Formulations has 2 current directors:
- Jagjit Singh Chahal - Director
- Paramjit Singh - Director
The latest financial statements of Tulip Formulations on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 September 2015. Year-wise statements from 2015 are in the company report.
No. Tulip Formulations has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Tulip Formulations is U24230HP2005PTC028713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tulip Formulations has 1 court case on record: 1 filed against it.
Tulip Formulations was incorporated on 25 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Tulip Formulations by revenue are Manmohini Pharmaceuticals Private Limited, Mendel Pharma Private Limited, Indinex Private Limited, Scion Pharma Private Limited, Cinicot Private Limited and 5 more, all in the Pharma industry (Formulations).
Jagjit Singh Chahal ceased to be Additional Director on 05 Jul 2011. Paramjit Singh ceased to be Additional Director on 05 Jul 2011. Anil Seth ceased to be Director on 04 Jul 2011. Tulip Formulations has 8 board changes on record in total.
The registered office of Tulip Formulations is at Village Surajpur Upla Tehsil Indora, Himachal Pradesh, India – 176001.
Tulip Formulations operates in the pharma industry, in the drug formulation and development segment.